0001629864-19-000001.txt : 20190531 0001629864-19-000001.hdr.sgml : 20190531 20190531145902 ACCESSION NUMBER: 0001629864-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 EFFECTIVENESS DATE: 20190531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AZTherapies, INC CENTRAL INDEX KEY: 0001629864 IRS NUMBER: 900747170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-340856 FILM NUMBER: 19870066 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET, 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-784-0490 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET, 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001629864 AZTherapies, INC 200 CLARENDON STREET, 17TH FLOOR BOSTON MA MASSACHUSETTS 02116 617-318-3411 DELAWARE None None Corporation true David R. Elmaleh 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director Robert S. Warren 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Keith Greenfield 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director David Taft 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Director Ronald Tompkins 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Director Peter Conti 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Director John Porter 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Director Gillian Sandler 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Director Karen Reeves 200 Clarendon Street, 17th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Biotechnology Decline to Disclose 06b false 2019-05-16 false true true false 0 7500000 5608027 1891973 false 11 0 0 0 No payments have been proposed other than payments of salaries in the ordinary course of business. false AZTherapies, INC David R. Elmaleh David R. Elmaleh, Ph.D. Chief Executive Officer 2019-05-31